Mydgf通过对FGF1进行升级来增强心脏血管生成
Yuyao Wang1, Weijing Liu2, Yanyan Hao3
1Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, 030001, China.
Journal of cardiovascular translational research
|June 24, 2025
概括
骨髓衍生生长因子 (Mydgf) 对于心脏血管生成和心脏病发作后的修复至关重要. 准Mydgf-FGF1通路促进血管生长,并可以治疗缺血性心脏病.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 再生医学是一种再生医学.
背景情况:
- 内皮细胞的增殖对于心肌梗塞 (MI) 后的新血管和心脏修复至关重要.
- 骨髓衍生生长因子 (Mydgf) 参与心脏修复,但其在血管生成中的作用尚不清楚.
研究的目的:
- 阐明Mydgf调节心脏血管生成的机制.
- 研究Mydgf-FGF1轴在缺血性心脏病中的治疗潜力.
主要方法:
- 利用骨髓衍生生长因子淘汰 (Mydgf-KO) 的小鼠模型来评估心脏血管生成和功能后MI.
- 采用液态染色体质谱法 (LC-MS) 来识别心脏细胞外基质中Mydgf的下游作用因子.
- 在实验室中使用复合FGF1蛋白评估内皮细胞增殖和管形成.
主要成果:
- 在MI后,Mydgf-KO小鼠表现出减少的内皮细胞增殖,受损的新血管化和恶化的心脏功能障碍.
- 重组MYDGF治疗成功地逆转了Mydgf-KO小鼠中的这些缺陷.
- 确定FGF1是Mydgf在血管生成中的关键下游效应因子,复合FGF1促进内皮细胞增殖和管形成.
结论:
- Mydgf-FGF1轴是心血管新生的一个关键调节器.
- 这种途径在促进血管修复方面具有显著的治疗前景,例如缺血性心脏病.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Mechanism of Angiogenesis
5.9K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.9K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K


